Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jordi Roca-Ferrer"'
Autor:
César Picado, Asuncion Martinez-Anton, Antonio Valero, Francisco de Borja Callejas, Isam Alobid, Laura Pujols, Joaquim Mullol, Jordi Roca-Ferrer
Publikováno v:
The Laryngoscope. 125:E158-E167
Objectives/Hypothesis To investigate the effect of oral plus intranasal corticosteroid (CS) treatment on nasal polyp (NP) mucosa remodeling from patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP). Study Design Case series, retrosp
Autor:
Asuncion Martinez-Anton, Pedro Benítez, Jordi Roca-Ferrer, W. J. Fokkens, Isam Alobid, J Mullol, Laura Pujols, César Picado
Publikováno v:
Allergy, 63(10), 1377-1386. Wiley-Blackwell
BACKGROUND: Poor response of nasal polyps to glucocorticoids (GCs) may be because of abnormal expression of GC receptors (GR) alpha and beta or to downregulation of GRalpha. We aimed to evaluate the in vivo regulation of GR isoforms in GC-treated nas
Autor:
J. Mullol, C de Bolós, Pedro Benítez, Isam Alobid, Jordi Roca-Ferrer, César Picado, Asuncion Martinez-Anton
Publikováno v:
Allergy. 63:1368-1376
Mucus hypersecretion is a hallmark of nasal polyposis (NP). Corticosteroids (CS) are first-line treatment for NP, decreasing their size and inflammatory component. However, their effect on mucin production is not well-understood. The aim of this (pil
Autor:
Francisco, de Borja Callejas, Asunción, Martínez-Antón, César, Picado, Isam, Alobid, Laura, Pujols, Antonio, Valero, Jordi, Roca-Ferrer, Joaquim, Mullol
Publikováno v:
The Laryngoscope. 125(5)
To investigate the effect of oral plus intranasal corticosteroid (CS) treatment on nasal polyp (NP) mucosa remodeling from patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP).Case series, retrospective study.Patients (n = 18) with
Publikováno v:
Scopus-Elsevier
BACKGROUND--Supernatants from epithelial cell cultures enhance eosinophil survival in vitro, this effect being abrogated by previous incubation of eosinophils with glucocorticosteroids. This property has resulted in the development of an in vitro tes
Autor:
Manuel Bernal-Sprekelsen, César Picado, Joaquim Mullol, Antoni Xaubet, James H. Shelhamer, Pedro Benítez, Jordi Roca-Ferrer
Publikováno v:
The Journal of allergy and clinical immunology. 108(1)
Airway hypersecretion is a common finding in rhinitis and asthma in which proinflammatory cytokines are upregulated. The effect of inflammation on glandular secretion remains unclear.We sought to investigate the effect of proinflammatory cytokines an
Autor:
Jordi Roca-Ferrer, Josep de Haro, James H. Shelhamer, Antoni Xaubet, Joaquim Mullol, María Honrubia Pérez, César Picado, Laureano Molins
Publikováno v:
The Journal of allergy and clinical immunology. 106(6)
Mucus hypersecretion is a hallmark of upper and lower airway diseases, such as rhinitis, asthma, and chronic obstructive pulmonary disease. Although topical glucocorticoids are widely used to treat mucosal inflammation, their effect on mucus hypersec
Publikováno v:
Respiratory medicine. 94(5)
Nasal epithelial cells maintain eosinophil survival by secreting granulocyte/macrophage colony-stimulating factor (GM-CSF). Corticosteroids antagonize eosinophil viability induced by GM-CSF. We investigated the effect of topical corticosteroids and n
Autor:
Laura Pujols, Jordi Roca-Ferrer, Antoni Xaubet, J.C. Fernández, E. López, César Picado, J Mullol
Publikováno v:
The European respiratory journal. 10(7)
Topical anti-inflammatory drugs decrease eosinophil infiltration. This action may be due to an effect on the release of epithelial cell products responsible for promoting eosinophil survival. We investigated the effect of fluticasone propionate, bude
Autor:
María Honrubia Pérez, J. Mullol, J. M. Fabra, Laura Pujols, Antoni Xaubet, César Picado, M. Fuentes, Jordi Roca-Ferrer
Publikováno v:
Respiratory Medicine. (5):408-414
We investigated the effect of budesonide and nedocromil sodium on the secretion of IL-6 and IL-8 by cultured epithelial cells from healthy nasal mucosa and nasal polyps. Human epithelial cell conditioned media was generated with fetal calf serum (FCS